HealthWell: Metabolic Dysfunction-Associated Steatohepatitis
Coverage RequiredNot Funded
About
The HealthWell Foundation MASH fund provides up to $8,000 per year in copay and premium assistance for patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH). Wegovy received FDA approval for MASH with liver fibrosis in August 2025, making it eligible under this fund when prescribed for MASH indication. Income must be at or below 500% of FPL.
Insurance requirements: Commercially Insured, Medicare / Medicaid
Enrollment Forms
HealthWell Online Application
Benefits
•$8000 annual maximum benefit
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: Yes
•Needs Based: Yes
•Activation Required: No
Program Details
•Up to $8,000 per year in copay and premium reimbursement assistance
•No minimum copay or premium reimbursement amount
•Wegovy is eligible when prescribed for MASH indication (FDA approved August 2025)
•Income must be at or below 500% of Federal Poverty Level
•Must have insurance covering the medication and receive treatment in the US
•Patients must submit Diagnosis Verification form within 30 days
•Grants valid for one full year; must use or reenroll
•First reimbursement request must be within 90 days of approval
•Grants inactive for 90+ days will be closed
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Enrollment Forms
HealthWell Online Application
Let us handle your prior authsJust enter your patient's info and we'll:
Utilize patient records to autofill forms with our AI in seconds.- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant